For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time vs placebo.

Solengepras shows strong potential as an adjunctive therapy for Parkinson’s, offering a novel, well-tolerated option with ...

Parkinson's disease cases are projected to surge by 112% globally by 2050, reaching 25.2 million. Early detection is crucial, ...

Shaking hands or tremors are a frequent symptom of Parkinson's, but not the only one. Read on as we debunk other myths.

It’s improving quality of life. Parkinson’s drugs are meant to keep patients in what’s called their “on state,” providing ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.